| 进口与国产头孢哌酮/舒巴坦钠治疗下呼吸道感染的成本-效果分析 |
| |
| 引用本文： | 刘安.进口与国产头孢哌酮/舒巴坦钠治疗下呼吸道感染的成本-效果分析[J].中国药房,2006,17(7):510-511. |
| |
| 作者姓名： | 刘安 |
| |
| 作者单位： | 西安市中心医院,西安市,710003 |
| |
| 摘 要： | 目的:评价进口与国产头孢哌酮/舒巴坦钠治疗下呼吸道感染的成本-效果。方法:对60例下呼吸道感染患者分别应用进口与国产头孢哌酮/舒巴坦钠(2∶1)进行治疗,观察疗效,并应用药物经济学成本-效果分析法进行评价。结果:2组成本分别为3164.00元、828.80元(P<0.05);有效率分别为83.3%、80.0%(P>0.05);成本-效果比分别为37.98、10.36;进口组相对于国产组的增量成本-效果比为707.64。结论:国产头孢哌酮/舒巴坦钠是更经济的选择。
|
| 关 键 词： | 头孢哌酮/舒巴坦钠 进口 国产 下呼吸道感染 成本-效果分析 |
| 文章编号： | 1001-0408(2006)07-0510-02 |
| 收稿时间： | 02 5 2006 12:00AM |
| 修稿时间： | 03 25 2006 12:00AM |
Treating Lower Respiratory Infection with Imported and Domestic Cefoperazone/ Sulbactam Sodium:Cost - effectiveness Analyses |
| |
| LIU An.Treating Lower Respiratory Infection with Imported and Domestic Cefoperazone/ Sulbactam Sodium:Cost - effectiveness Analyses[J].China Pharmacy,2006,17(7):510-511. |
| |
| Authors: | LIU An |
| |
| Abstract: | OBJECTIVE:To evaluate the cost-effectiveness of imported and domestic cefoperazone/sulbactam sodium in treating lower respiratory infection.METHODS:60patients with lower respiratory infections were ascribed to receive im-ported or domestic cefoperazone/sulbactam sodium(2∶1)respectively,the curative effects of the drugs were monitored and evaluated by cost-effectiveness analysis.RESULTS:The costs of the two groups were3164.00yuan and828.80yuan,re-spectively(P<0.05);The effective rates were83.3%and80.0%(P>0.05),respectively;The cost-effectiveness ratios were37.98and10.36,respectively;And the incremental cost-effectiveness ratio of the imported group vs.the domestic group was707.64.CONCLUSION:Domestic cefoperazone/sulbactam sodium is a more economical choice. |
| |
| Keywords: | Cefoperazone/ sulbactam sodium Imported Domestic Lower respiratory infection Cost - effectiveness analysis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
